Preventing infective complications in inflammatory bowel disease

doi:10.3748/wjg.v20.i29.9691

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 29

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8202)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

478

WORD

235

HTML

3885

Figures (1-1)

279

Tables (1-1)

218

Sum=5095

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

757

Download

670

Sum=1427

Publishing Process of This Article

Item

Count

Browse

886

Download

794

Sum=1680

Aug 7, 2014 (publication date) through Dec 24, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 7, 2014; 20(29): 9691-9698
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.9691

Table 1 Vaccines recommended in immunocompromised inflammatory bowel disease patients

Infectious disease	Vaccine type	Recommendation
Influenza	Inactivated trivalent virus	Recommended annually
Pneumococcal disease	23-valent purified capsular antigen	Recommended 5 yearly
Hepatitis B virus	Recombinant peptide	Recommended standard or double dose schedule
Human papilloma virus	Quadrivalent vaccine	In women according to local guidelines, standard schedule
Tetanus-Diptheria	Toxoid	Recommended in vaccinated patients 10 yearly
Measles-Mumps-Rubella	Live attenuated	Contraindicated
Varicella zoster	Live attenuated	Contraindicated
Yellow fever	Live attenuated	Contraindicated
Cholera	Oral live	Contraindicated
Cholera	Oral killed	Use with caution
Poliomyelitis	Oral live attenuated	Contraindicated
Poliomyelitis	Injectable inactivated	Recommended
Meningococcal	Conjugated polysaccharide	Authorised yet not recommended
Meningococcal	C polysaccharide combined	Authorised yet not recommended
Tuberculosis	BCG live vaccine	Always contraindicated

BCG: Bacille Calmette-Guérin.

Citation: Mill J, Lawrance IC. Preventing infective complications in inflammatory bowel disease. World J Gastroenterol 2014; 20(29): 9691-9698
URL: https://www.wjgnet.com/1007-9327/full/v20/i29/9691.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i29.9691